Abnormalities of neural circuitry in Alzheimer's disease: hippocampus and cortical cholinergic innervation - PubMed (original) (raw)
Review
. 1998 Jul;51(1 Suppl 1):S18-29; discussion S65-7.
doi: 10.1212/wnl.51.1_suppl_1.s18.
Affiliations
- PMID: 9674759
- DOI: 10.1212/wnl.51.1_suppl_1.s18
Review
Abnormalities of neural circuitry in Alzheimer's disease: hippocampus and cortical cholinergic innervation
C Geula. Neurology. 1998 Jul.
Abstract
Severe pathology in Alzheimer's disease (AD) results in marked disruption of cortical circuitry. Formation of neurofibrillary tangles, neuronal loss, decrease in dendritic extent, and synaptic depletion combine to halt communication among various cortical areas, resulting in anatomic isolation and fragmentation of many cortical zones. The clinical manifestation of this disruption is severe and debilitating cognitive dysfunction, often accompanied by psychiatric and behavioral disturbances and a diminished ability to perform activities of daily living. However, different cortical circuits are not equally vulnerable to AD pathology. In particular, two cortical systems that appear to be involved in the neural processing of memory are selectively vulnerable to degeneration in AD. One consists of connections between the hippocampus and its neighboring cortical structures within the temporal lobe. The second is the cortical cholinergic system that originates in neurons within the basal forebrain and innervates the entire cortical mantle. The circuitry in these systems shows early and severe degenerative changes in the course of AD. The selective vulnerability of these circuits is the probable reason for the early and marked loss of memory observed in these patients. This review presents current knowledge of the general pattern of cortical circuitry, followed by a summary of abnormalities of this circuitry in AD. The cortical circuits that exhibit selective pathology in AD are described in greater detail. Therapeutic implications of the abnormal circuitry in AD are also discussed. For therapies to be effective, early diagnosis of AD is necessary. Future efforts at AD therapy must be combined with an equally intense effort to develop tools capable of early diagnosis of AD, preferably at a preclinical stage before the onset of cognitive symptoms.
Similar articles
- The cholinergic system in aging and neuronal degeneration.
Schliebs R, Arendt T. Schliebs R, et al. Behav Brain Res. 2011 Aug 10;221(2):555-63. doi: 10.1016/j.bbr.2010.11.058. Epub 2010 Dec 9. Behav Brain Res. 2011. PMID: 21145918 Review. - Systematic regional variations in the loss of cortical cholinergic fibers in Alzheimer's disease.
Geula C, Mesulam MM. Geula C, et al. Cereb Cortex. 1996 Mar-Apr;6(2):165-77. doi: 10.1093/cercor/6.2.165. Cereb Cortex. 1996. PMID: 8670647 - [Selective stimulations and lesions of the rat brain nuclei as the models for research of the human sleep pathology mechanisms].
Šaponjić J. Šaponjić J. Glas Srp Akad Nauka Med. 2011;(51):85-97. Glas Srp Akad Nauka Med. 2011. PMID: 22165729 Review. Serbian. - Neurofibrillary degeneration of cholinergic and noncholinergic neurons of the basal forebrain in Alzheimer's disease.
Rasool CG, Svendsen CN, Selkoe DJ. Rasool CG, et al. Ann Neurol. 1986 Oct;20(4):482-8. doi: 10.1002/ana.410200407. Ann Neurol. 1986. PMID: 3539000 - The cholinergic lesion of Alzheimer's disease: pivotal factor or side show?
Mesulam M. Mesulam M. Learn Mem. 2004 Jan-Feb;11(1):43-9. doi: 10.1101/lm.69204. Learn Mem. 2004. PMID: 14747516 Review.
Cited by
- Fractal Phototherapy in Maximizing Retina and Brain Plasticity.
Zueva MV, Neroeva NV, Zhuravleva AN, Bogolepova AN, Kotelin VV, Fadeev DV, Tsapenko IV. Zueva MV, et al. Adv Neurobiol. 2024;36:585-637. doi: 10.1007/978-3-031-47606-8_31. Adv Neurobiol. 2024. PMID: 38468055 - Blockage of VEGF function by bevacizumab alleviates early-stage cerebrovascular dysfunction and improves cognitive function in a mouse model of Alzheimer's disease.
Zhang M, Zhang Z, Li H, Xia Y, Xing M, Xiao C, Cai W, Bu L, Li Y, Park TE, Tang Y, Ye X, Lin WJ. Zhang M, et al. Transl Neurodegener. 2024 Jan 3;13(1):1. doi: 10.1186/s40035-023-00388-4. Transl Neurodegener. 2024. PMID: 38173017 Free PMC article. - Regional Precuneus Cortical Hyperexcitability in Alzheimer's Disease Patients.
Casula EP, Borghi I, Maiella M, Pellicciari MC, Bonnì S, Mencarelli L, Assogna M, D'Acunto A, Di Lorenzo F, Spampinato DA, Santarnecchi E, Martorana A, Koch G. Casula EP, et al. Ann Neurol. 2023 Feb;93(2):371-383. doi: 10.1002/ana.26514. Epub 2022 Oct 18. Ann Neurol. 2023. PMID: 36134540 Free PMC article. - Effect of acetylcholine deficiency on neural oscillation in a brainstem-thalamus-cortex neurocomputational model related with Alzheimer's disease.
Yang H, Yang X, Yan S, Sun Z. Yang H, et al. Sci Rep. 2022 Sep 2;12(1):14961. doi: 10.1038/s41598-022-19304-3. Sci Rep. 2022. PMID: 36056083 Free PMC article. - Hippocampal neural circuit connectivity alterations in an Alzheimer's disease mouse model revealed by monosynaptic rabies virus tracing.
Ye Q, Gast G, Su X, Saito T, Saido TC, Holmes TC, Xu X. Ye Q, et al. Neurobiol Dis. 2022 Oct 1;172:105820. doi: 10.1016/j.nbd.2022.105820. Epub 2022 Jul 14. Neurobiol Dis. 2022. PMID: 35843448 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical